Optometrists in Milford, NH Accepting Medicare
7 Optometrists found. Showing 1 - 7
 Kaitlyn Ann Gregory, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 603 Nashua St, Milford, NH 03055 Phone: 603-672-0338 Fax: 602-672-5228 |
Dr. Suzanna Mary Schmitt, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 577nashua St, Milford, NH 03055 Phone: 603-672-0338 Fax: 602-672-5228 |
Dr. Sharon Grove Perkins, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 81 Mont Vernon Rd, Milford, NH 03055 Phone: 603-673-1330 |
 Philip S Aubrey Od Optometrist Medicare: Not Enrolled in Medicare Practice Location: 81 Mont Vernon Street, Milford, NH 03055 Phone: 603-673-1330 |
 Dr. Joseph Raczek, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 577 Nashua St, Milford, NH 03055 Phone: 603-672-0338 Fax: 602-672-5228 |
Myeyedr. Optometrist Medicare: Medicare Enrolled Practice Location: 577 Nashua St, Milford, NH 03055 Phone: 603-672-0338 Fax: 602-672-5228 |
Dr. Philip Aubrey, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 81 Mont Vernon Rd, Milford, NH 03055 Phone: 603-673-1330 Fax: 603-673-7007 |
News Archive
IPC to distribute AP's Promescent in US for treatment of premature ejaculation
The Independent Pharmacy Cooperative and Absorption Pharmaceuticals have signed a distribution agreement whereby IPC will make AP's topical treatment for premature ejaculation, Promescent, available to its 4,500+ member pharmacies throughout the United States.
Elevated amounts of SP2 protein turn stem cells into cancerous tumors: Research
Researchers at North Carolina State University have found that the overproduction of a key protein in stem cells causes those stem cells to form cancerous tumors. Their work may lead to new treatments for a variety of cancers.
Study to assess benefits of plasma administration while being flown to hospitals
Vanderbilt University Medical Center will participate in a national trial to see if outcomes for critically injured patients with uncontrolled bleeding can be improved by administering plasma to these patients while in flight to the hospital.
Chemotherapy drug gemcitabine delays progression of operable pancreatic cancer
Barcelona, Spain: Giving pancreatic cancer patients the chemotherapy drug gemcitabine after surgery delays progression of the disease by about six months, according to new research by Japanese scientists.
› Verified 6 days ago
Physical Therapists
Occupational Therapists
Chiropractors
Optometrists
Speech-Language Pathologists